Pharyngitis Market Statistics for Upcoming Trends, Share, Size and Opportunity through 2017-2026

A sore throat or pharyngitis is caused when a virus infects the area of the throat. Some of the most common causes of pharyngitis is viral infections such as the influenza and common cold. Acute pharyngitis is one of the most common condition, hence, there has been an increase in demand for systematic treatment and medication. Drug manufacturers are also focusing on research and development of new drugs to treat pharyngitis without causing any side-effects. This FactMR report analyzes the expansion of global Pharyngitis Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. The scope of FactMR’s report is to analyze the global pharyngitis market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global pharyngitis market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to pharyngitis. The report commences with a brief information of the global pharyngitis market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global pharyngitis market.

You can Get Free Sample Report about Market Here – https://www.factmr.com/connectus/sample?flag=RC&rep_id=361

Pharyngitis commonly known as a sore throat is caused by viral or bacterial infection. The most common bacteria infecting throat is Group A streptococcus. Various clinical trials are being carried on to find the best formulation effective in treating sore throat. There is also a focus on patients receiving medication as per the clinical needs and also meet their individual requirement. The healthcare industry across the globe is also emphasizing on appropriate diagnosis, drug selection, dosage, and drug delivery route, duration of administration, proper follow-up, and correct information on possible side-effects.

The latest study by FactMR expects the global market for pharyngitis to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue. Pharyngitis is the most common manifestation of infection. Antibiotics are given in case of a sore throat, however, they provide very modest benefit. It is still unclear which antibiotic is the best for the treatment of a sore throat. Hence, various research and trials are being conducted to find most effective antibiotic.

Beta Lactams to Emerge as the Most-Preferred Drug Class

Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their use.

You can Browse Complete Market Report In-Depth Here – https://www.factmr.com/report/361/pharyngitis-market

Retail Pharmacies and Drug Stores to Emerge as the Biggest Distribution Channel

Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain.

Oral Drug Delivery to Gain Maximum Traction between 2017 and 2026

Oral drug delivery is likely to emerge as the most-preferred drug administration route. Oral drug delivery is projected to create an incremental opportunity of over US$ 300 million between 2017 and 2026. Owing to the cost-effectiveness, convenience and high patient compliance, oral drug delivery is witnessing significant growth. However, many drugs are poorly bioavailable when administered. Hence, lipid-based drug delivery system is one of the emerging trends addressing bioavailability challenges. Moreover, oral drug delivery is the least invasive method as compared to other routes. Targeted drug delivery is also an emerging trend, in which the drug is active only in the targeted area.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global pharyngitis market through 2026, which include Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals, Inc., and Zambon Group SpA.

You can Buy This Market Report from Here – https://www.factmr.com/checkout/361/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized global market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us –

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/